Defilade Capital Management, L.P.

Est. AUM

$712.2M

13F long equity, this entity only

Positions

Period

Mar 2026 (Q1)

SEC EDGAR

Mar 2026 (Q1)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	ZIMMER BIOMET HOLDINGS INC	COM	$52.4M	579161	7.35%	SOLE
2	SCHEIN HENRY INC	COM	$46.0M	624037	6.46%	SOLE
3	BECTON DICKINSON & CO	COM	$43.9M	279210	6.16%	SOLE
4	PTC THERAPEUTICS INC	COM	$41.1M	376165	5.77%	SOLE
5	DEXCOM INC	COM	$33.8M	538762	4.75%	SOLE
6	ICU MED INC	COM	$32.8M	254291	4.61%	SOLE
7	INSMED INC	COM PAR $.01	$31.9M	194909	4.48%	SOLE
8	INTUITIVE SURGICAL INC	COM NEW	$31.2M	67681	4.38%	SOLE
9	REVOLUTION MEDICINES INC	COM	$30.7M	315972	4.31%	SOLE
10	GLOBUS MED INC	CL A	$30.5M	354350	4.29%	SOLE
11	NEUROCRINE BIOSCIENCES INC	COM	$27.7M	209932	3.88%	SOLE
12	DENALI THERAPEUTICS INC	COM	$26.1M	1359969	3.67%	SOLE
13	PACS GROUP INC	COM SHS	$25.6M	604180	3.60%	SOLE
14	OLEMA PHARMACEUTICALS INC	COM	$22.4M	1504536	3.15%	SOLE
15	ELANCO ANIMAL HEALTH INC	COM	$22.3M	931121	3.13%	SOLE
16	PFIZER INC	COM	$19.4M	1464129	2.72%	SOLE
17	ELI LILLY & CO	COM	$19.0M	20696	2.67%	SOLE
18	LANTHEUS HLDGS INC	COM	$18.9M	249401	2.66%	SOLE
19	INTEGER HLDGS CORP	COM	$18.7M	213027	2.63%	SOLE
20	BIOGEN INC	COM	$17.7M	96289	2.48%	SOLE
21	EVOMMUNE INC	COM SHS	$15.6M	678589	2.19%	SOLE
22	TANDEM DIABETES CARE INC	COM NEW	$14.6M	761905	2.05%	SOLE
23	COGENT BIOSCIENCES INC	COM	$13.6M	352590	1.91%	SOLE
24	NUVALENT INC	COM	$13.3M	129950	1.87%	SOLE
25	OCULAR THERAPEUTIX INC	COM	$12.6M	1487645	1.77%	SOLE
26	ASCENDIS PHARMA A/S	SPONSORED ADR	$11.9M	51895	1.67%	SOLE
27	ALIGN TECHNOLOGY INC	COM	$11.5M	67332	1.62%	SOLE
28	ELEDON PHARMACEUTICALS INC	COM	$11.0M	3564127	1.54%	SOLE
29	ORIC PHARMACEUTICALS INC	COM	$10.7M	842928	1.50%	SOLE
30	BIOHAVEN LTD	COM	$2.7M	315944	0.38%	SOLE
31	MEREO BIOPHARMA GROUP PLC	SPON ADS	$2.5M	7558756	0.35%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.